The challenges of treating moderate to severe psoriasis.
Gottlieb
A B
AB
Division of Dermatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick 08901, USA.
D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008134:Long-Term Care / Q000191:economics; D011701:PUVA Therapy; D011565:Psoriasis / Q000145:classification / Q000191:economics* / Q000628:therapy*; D012074:Remission Induction
D007166:Immunosuppressive Agents; D016572:Cyclosporine